Health Care
PROTAGONIST THERAPEUTICS INC PTGX
$140.89
Price at quarter end (Q3 2026)
Superinvestor owners
1
Rank #1391 by number of owners
% of all portfolios
0.00%
Rank #1365 by combined value
Net managers Q2 2026
0
No one entered or exited
Hold price
—
Weighted avg. reported price
Largest position
0.0%
of Polen Capital's portfolio
Live price
Compare with the quarter-end price of $140.89 reported in the 13F
Superinvestors holding PTGX
| Recent activity | |||
|---|---|---|---|
| Polen Capital · Polen Capital Management | 0.0% | ▼ Reduce-7.5% | $3.0M |